HIV testing and care outreach: screening pages, self-tests, window periods, undetectable wording, reminder texts and Part 2 referrals

HIV testing outreach asks people who feel well to take a test they may have put off, and it asks them to trust the program with a deeply private result. The program may be a primary care office that adds the test to its recall list, a community health center or a free clinic that runs testing days, a sexual health clinic, a substance use treatment program or a syringe services partner that tests on site, a pharmacy, an urgent care clinic, or an HIV care practice that takes referrals after a positive result. This guide covers how to build a testing page on the federal recommendations, how to describe self-tests and window periods without overstating them, how to write about undetectable viral load in the words federal sources use, how to word outreach texts and mailers, how referrals from substance use programs meet 42 CFR Part 2, and how free tests, coverage and partners meet the federal rules.

Ten related topics have their own guides and are not repeated here. Prevention medicine is covered in our guide to PrEP clinic marketing, and testing for other sexually transmitted infections in our guide to sexual health clinic marketing. Hepatitis C testing is covered in our guide to hepatitis C testing and treatment outreach, treatment programs in our guide to addiction treatment marketing, and health centers in our guide to community health center marketing. Pop-up testing is covered in our guides to health fair and screening event marketing and mobile health clinic marketing, pharmacy testing in our guide to pharmacist test and treat marketing, mail-in kits in our guide to direct-to-consumer lab testing marketing, and reminder texts in our guide to text message appointment reminders. For prenatal syphilis screening wording, see syphilis testing outreach.

What the federal sources say

The US Preventive Services Task Force (USPSTF), the CDC, HIV.gov from the Department of Health and Human Services, and MedlinePlus from the National Library of Medicine publish the federal positions on HIV testing and care. The points that shape an outreach program’s marketing:

• The USPSTF final recommendation Human Immunodeficiency Virus (HIV) Infection: Screening (June 11, 2019) recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years and in all pregnant persons, both grade A recommendations. It says that, as recommended by the CDC, HIV screening should be voluntary and performed only with the patient’s knowledge and understanding. The page now states that the topic is being updated.
• The CDC page Getting Tested for HIV (updated September 15, 2026, read through an archived copy) says everyone between the ages of 13 and 64 should get tested for HIV at least once, that people with certain risk factors should get tested at least once a year, and that HIV testing should be performed during each pregnancy. It says free or reduced cost HIV tests are available, and points readers to its own testing locator.
• The same CDC page says a positive result on any antibody test needs a follow-up test to confirm it, that a person who tests positive at a community program or with a self-test should go to a health care provider for follow-up testing, and that testing positive for HIV does not mean a person has AIDS. It says a negative result does not necessarily mean a person does not have HIV, because of the window period, the time between an exposure and when a test can detect HIV.
• The HIV.gov page Viral Suppression and an Undetectable Viral Load (updated October 14, 2026) says treatment with HIV medicine is recommended for all people living with HIV, and that HIV treatment does not cure HIV. The MedlinePlus page HIV (last updated March 26, 2025) says there is no cure for HIV infection, but it can be treated with medicines.
• The MedlinePlus test page HIV Screening Test (last updated May 6, 2025) says HIV testing can be anonymous, which means a person does not have to give a name and receives a number instead.

Because MedlinePlus is more than a year old and agency statements that there is no cure can change, we checked the newer HIV.gov treatment page, updated October 14, 2026, which also says treatment does not cure HIV. The USPSTF recommendation is more than seven years old and its page says an update is in progress; its age range of 15 to 65 also differs from the CDC range of 13 to 64. Name the source next to each age range, and check the USPSTF site for the updated recommendation at each review.

Two points shape the marketing. First, the federal recommendation is for adolescents and adults in general, so an outreach message does not need to ask anyone to admit to anything: it can say CDC recommends that people aged 13 to 64 get tested at least once, and that the test is voluntary and private. Second, the honest message is a hopeful one, but a reactive result needs a follow-up test, a negative result may need a repeat test after the window period, and treatment controls HIV rather than curing it, so the copy has to keep each of those lines straight.

Testing pages and claims that need rewriting

Google’s search suggestions, which we checked on October 30, 2026, offer “hiv testing near me”, “hiv test at home”, “hiv test non reactive means”, “hiv test results”, “hiv testing near me free” and “hiv test price” to a person who types “hiv test”, “hiv testing window period” after “hiv testing”, “free hiv testing near me”, “free hiv test kit” and “free hiv test by mail” after “free hiv”, and “hiv home test accuracy” after “hiv home test”. A testing page can answer each of those honestly: who the test is for, what a nonreactive or reactive result means and what happens next, what the window period is, how a self-test works and what to do after a positive one, and what the test costs and who pays.

A page that holds up says that CDC recommends an HIV test for people aged 13 to 64 at least once, that the test is voluntary, how the sample is taken, when results come back, who calls with them and how, and what the next step is for each result. Leave the risk factor list for the clinician or counselor conversation or link the CDC page, rather than making it the headline, and do not write a headline that singles out sex between men or drug use.

Phrases that need rewriting:

• “Know your status in 20 minutes.” CDC says a negative result may need a repeat test after the window period, and a positive rapid or self-test result needs a follow-up test. Say when the result is ready and what it does and does not tell the person.
• “A positive rapid test means you have HIV.” CDC says a positive antibody test needs a follow-up test to confirm it. Explain the two steps.
• “Negative today means you are HIV free.” CDC says a negative result does not necessarily mean a person does not have HIV, because of the window period. Explain the window period for the test the program uses.
• “HIV is curable now” or “beat HIV for good”. HIV.gov and MedlinePlus say treatment does not cure HIV. Remove it, and say instead that HIV can be treated.
• “Only gay men and drug users need this test.” CDC recommends a test for everyone aged 13 to 64 at least once. Remove it.
• “Our clinic has helped 300 patients reach undetectable.” An outcome number with no source. Remove it unless it is drawn from the program’s own documented and reviewed records, with its date and limits stated.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. Quoting CDC or HIV.gov as written, with the source named, stays inside that standard; turning a federal statement into a promise to the reader does not.

Urgent signs and 911 on every page and in every tool

One message matters more than any other on an HIV testing page. The HIV.gov page Post-Exposure Prophylaxis (PEP) (updated October 28, 2026) says PEP must be started within 72 hours of a possible exposure, and that a person who thinks they were recently exposed should contact a health care provider or local health department immediately or go to an emergency room or urgent care clinic right away. Put plain lines above the booking button and on event flyers: if you think you were exposed to HIV in the last 72 hours, call [phone] now or go to an emergency room or urgent care clinic today, and do not wait for a testing appointment. Call 911 for any medical emergency, including an overdose. If you are thinking about suicide or are in crisis, call or text 988. Ask the program’s clinicians to review each line before it goes live.

The same wording belongs in voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools, and on the card handed out at a testing event. A tool should hand any message about a recent exposure to a clinician or the on-call line at once, send any message about an emergency or an overdose to the 911 line and alert staff, send any message about self-harm to the 988 line and alert staff, pass questions about results to a clinician or counselor, and never explain a test result itself. Our guides to the AI chatbot on a practice website and answering service versus AI receptionist cover how tools hand off these messages.

Self-tests, rapid tests and window periods

Programs that hand out self-tests or run rapid tests want to say how fast and how easy testing is. The HIV.gov page HIV Testing Overview (updated August 28, 2026) says a self-test gives results within 20 minutes, that there are only two rapid self-tests currently approved by the FDA, that results should be read according to the manufacturer’s instructions, that a positive self-test needs a second test from a health care provider, and that state laws on self-testing vary and may limit availability. The CDC page says the window period depends on the type of test: CDC gives 23 to 90 days after exposure for antibody tests, 18 to 90 days for a rapid antigen/antibody test from a finger stick, 18 to 45 days for an antigen/antibody lab test from a vein, and 10 to 33 days for a nucleic acid test, and it describes the HIV self-tests approved by FDA as antibody tests.

That gives a program clear words to use. A page can say the program offers a rapid test or a free self-test kit, say how long the result takes, explain how a positive result is confirmed with a follow-up test, and explain that a person tested soon after a possible exposure may need a repeat test after the window period. Use the FDA term from the test’s own record, name no test or product in ads, and describe a mail-in kit only by what its own instructions and FDA record say; our guide to medical device marketing claims covers the wider rules.

Phrases that need rewriting:

• “100 percent accurate home HIV test.” No test can detect HIV right after infection, as CDC explains. Remove the figure and explain the window period.
• “FDA-approved test kit” for a kit the program has not checked. HIV.gov says only two rapid self-tests are currently approved by the FDA. Check the kit’s own FDA record before using the word.
• “Test at home, no doctor needed.” HIV.gov says a positive self-test needs a second test from a health care provider. Say how the program helps with that next step.

Supplements offered to people living with HIV need the same care. The FDA Questions and Answers on Dietary Supplements (content current as of August 27, 2026) says FDA does not have the authority to approve dietary supplements before they are marketed. Name no product, make no claim that a supplement treats HIV or boosts the immune system, and follow our guide to selling supplements in a medical practice.

Undetectable wording: use the federal text

Care practices want to say what treatment makes possible. HIV.gov says that people living with HIV who take HIV medicine as prescribed and get and keep an undetectable viral load will not transmit HIV to their HIV-negative partners through sex, and it gives this the names treatment as prevention and undetectable = untransmittable (U=U). The same page says an undetectable viral load does not prevent other sexually transmitted infections, that HIV is still in the body when the viral load is undetectable, and that skipped doses can make the viral load rise again.

Use that statement in the federal words, with HIV.gov named as the source, and keep its conditions attached: taking medicine as prescribed, getting and keeping an undetectable viral load, and transmission through sex. Do not shorten it into a claim about every route of transmission, and do not write it as a promise about a particular reader’s result. Name no medicine in marketing copy; the choice of treatment belongs to the clinician and the patient.

Phrases that need rewriting:

• “Undetectable means HIV is gone.” HIV.gov says HIV is still in the body when the viral load is undetectable. Remove it.
• “Undetectable means you can’t pass HIV in any way.” HIV.gov ties the no-transmission statement to sex, and describes other routes separately. Quote the statement with its conditions.
• “Start treatment with us and be undetectable in weeks.” A personal promise and a timeline. Say that HIV.gov reports treatment can lower the viral load to undetectable when medicine is taken as prescribed, and that the clinician explains the plan.

Outreach texts, letters and recall lists

Outreach programs reach people through recall lists: patients with no HIV test on file, people whose rapid or self-test was positive but who never had the follow-up test, people who were tested inside the window period and need a repeat test, and people diagnosed with HIV who have not returned for care. Under 45 CFR 164.501, a communication about the practice’s own treatment for an individual, such as a reminder to come in for a recommended test or a follow-up visit, can fall outside the definition of marketing, while a message that promotes a third party’s product or service generally needs a signed authorization under 45 CFR 164.508. Rules on the confidentiality of HIV test results are also set state by state, and counsel should review the outreach plan against them.

The words in the message matter as much as the rule. A text, a postcard or a voicemail can be seen by someone else in the household. Keep these points:

• Name no condition, no test result and no risk factor in the message text. Write “[Practice name] has a recommended screening for you. Call [phone] or book online.” and give the details only after the person signs in or calls.
• Do not mention HIV on an envelope, a postcard or a caller ID name, and do not leave a result on voicemail.
• Use the contact method the patient chose, and honor opt-out requests in every channel.
• Do not send recall lists, test results or appointment data to an ad platform to build an audience.

Our guides to text message appointment reminders and the patient recall system cover consent, timing and opt-outs.

Referrals from substance use programs and 42 CFR Part 2

Testing and care programs that work with substance use treatment providers receive referrals that may carry records protected by a stricter federal rule. Under 42 CFR 2.12, the Part 2 rules apply to records of the identity, diagnosis, prognosis or treatment of a patient kept in connection with a federally assisted substance use disorder program. Under 42 CFR 2.31, a written consent to use or disclose those records must include, among other elements, the patient’s name, who may make the disclosure, who receives it, a description of each purpose, and an expiration date or event.

For marketing and outreach, that means:

• Do not ask a treatment program for a list of its patients to contact for testing. A referral comes from the patient’s own consent, and the outreach message comes from the program that holds the relationship.
• Do not publish a partner program’s name beside a testing offer in a way that tells readers the people tested there are in substance use treatment, unless counsel has reviewed it.
• Keep referral forms off general web forms and away from tracking tools; route them through the secure channel the two programs agreed on in writing.
• Write about drug use and sex without labels. Say “people who inject drugs” as CDC and HIV.gov do, and never use a word that blames the reader.

Our guide to addiction treatment marketing covers Part 2 for treatment programs themselves.

Free tests, coverage and care costs

Coverage pages draw the “hiv testing near me free” and “hiv test price” searches. The Medicare.gov page Human Immunodeficiency Virus (HIV) screenings, checked on October 30, 2026, says Part B covers HIV screening for people aged 15 to 65, and for people younger than 15 or older than 65 who are at increased risk, once a year, and up to 3 times during a pregnancy, and that the person pays nothing if the provider accepts assignment. Describe Medicare coverage in those terms, and say the program checks coverage for each patient’s plan. Medicaid coverage of testing and care is set state by state; our guides to marketing to Medicare patients and marketing to Medicaid patients cover the wider rules.

Care costs belong in the clinician and billing conversation, not in an ad. Do not write “free HIV care” or “treatment at no cost to you” unless the program has confirmed it for each person it reaches. Cash testing prices follow our guides to advertising cash prices and good faith estimates for self-pay patients.

A “free” test, a free self-test kit, a gift card for getting tested or a meal at a testing event follows 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere, and that the terms of the offer should be stated at the outset. Under 42 U.S.C. 1320a-7a(a)(5), civil penalties can apply to a person who offers or transfers remuneration to a Medicare or state health care program beneficiary that the person knows or should know is likely to influence the beneficiary to order or receive items or services from a particular provider, practitioner or supplier. Incentives for testing or for returning to care need counsel’s review before they run, and a grant-funded program should also check its grant terms.

Partners, sponsors and referral payments

Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Rules on referral fees are also set state by state.

For an HIV testing and care program, keep these points:

• Do not accept free staff, test kits, event funding or marketing help from a drug maker, a lab or a pharmacy tied to the tests or prescriptions the program orders, without counsel’s review; our guide to Open Payments covers reported payments from manufacturers.
• Give patients a choice of pharmacy and lab, and do not steer prescriptions or samples to one company in exchange for anything of value.
• Do not pay a shelter, a treatment program, an outreach worker, a venue or a marketing company per person tested or per person who starts care without counsel’s review.
• Referral arrangements with primary care offices, HIV care practices and community partners follow our guide to patient and physician referrals.

Privacy, pixels and ads

A visit to an HIV testing page, a results question or a booking form says something about a person’s health and may hint at their sex life or drug use. Keep form answers, bookings and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place and by search terms, and should not be built from a list of patients or people who were tested. If the program offers anonymous testing, as MedlinePlus says HIV testing can be, make sure the booking flow does not ask for a name it does not need.

Tone and patient stories

People who hear about an HIV test may carry fear about the result and shame about how they might have been exposed. Lead with the recommendation for adolescents and adults, explain each step in plain words, say who will call with results and how, and say that people who test positive can get care. Avoid photos or wording that suggest who “looks like” a person with HIV, use person-first words such as “people living with HIV” as HIV.gov does, and offer the page in the languages the program’s patients read.

A story from a person who was tested and is living well with HIV is a strong message for outreach. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. Pair the story with the attributed federal statement, say results differ, and get a signed authorization under 45 CFR 164.508 where the program is a covered entity. A story should not say how the person acquired HIV unless they chose to share it, should not show their face or name unless they asked for it in writing, and should name no medicine; say if the person received anything for taking part, and let them review the final version. Our guides to patient photo consent and testimonials and before and after photos cover the full rules.

Illustration: two testing outreach messages

Illustration: a flyer reads “Hooking up a lot? Get your HIV test! FDA-approved 20-minute test, 100 percent accurate, know for sure today. HIV is curable now: start meds with us and be undetectable in weeks, and then you can’t pass it on, ever. Free care and a free gift card for everyone tested!” It singles out sex, calls a test approved without checking its record, gives an accuracy figure with no source, ignores the window period and the follow-up test, calls HIV curable, promises a personal result and a timeline, drops the conditions on the federal undetectable statement, promises free care without checking coverage, and offers a gift card without counsel’s review.

Illustration: a second flyer for the same program reads “CDC recommends that everyone aged 13 to 64 get an HIV test at least once. At [Practice name] the test is voluntary and private, and it takes a finger stick or a small blood sample. If a rapid test is positive, a follow-up test confirms the result. If you were exposed recently, you may need a repeat test later, and we will tell you when. We call you with results within [days]. If you think you were exposed to HIV in the last 72 hours, call [phone] now or go to an emergency room today. Call 911 for an emergency. Call [phone] during [days and hours] to book.” It speaks to all adults, explains the follow-up and the window period, and puts the exposure and emergency lines first.

Checklist before an HIV testing outreach campaign goes live

• Testing copy built on the CDC and USPSTF recommendations, with each source named and dated next to its own age range, and the USPSTF page checked for the update in progress at each review.
• No headline that singles out sex between men, sex work or drug use; the risk factor list left for the clinician or counselor or linked to CDC.
• Positive rapid and self-test results explained as needing a follow-up test; negative results explained with the window period for the test the program uses.
• No cure claim; HIV described as treatable, in the words of HIV.gov and MedlinePlus; no medicine named in marketing copy.
• The undetectable statement quoted from HIV.gov with its conditions and source, never shortened or written as a promise or a timeline.
• Self-tests and rapid tests described by their own FDA record and instructions; no accuracy figure without a source; no “FDA approved” without checking the record.
• The 72-hour exposure line, the 911 line and the 988 line on pages, flyers, event cards, voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools, reviewed by the program’s clinicians.
• Outreach texts, postcards, caller ID names and voicemails name no condition, result or risk factor; opt-outs honored; state rules on HIV result confidentiality reviewed by counsel.
• Referrals from substance use programs only with the patient’s written consent under 42 CFR 2.31; no patient lists from partners.
• Medicare coverage described as Medicare.gov states it; coverage checked per patient; no “free care” unless confirmed.
• Free tests, self-test kits, gift cards and event incentives reviewed by counsel under 16 CFR 251.1 and 42 U.S.C. 1320a-7a(a)(5), and against grant terms.
• No free staff, kits or funding from drug makers, labs or pharmacies tied to orders, and no per-person payments to partners or venues, without counsel’s review.
• Form answers, bookings and test lists stay out of pixels and ad audiences; anonymous testing offered where the program can; stories have signed authorizations, name no medicine and say results differ.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including primary care, community health, sexual health, HIV care and addiction medicine practices. For an HIV testing and care program, that means a site that builds its testing page on the CDC and USPSTF recommendations as written and dated, explains follow-up tests and window periods in plain words, quotes the undetectable statement with its conditions, puts the 72-hour exposure, 911 and 988 lines above the booking button, and answers “hiv testing near me” and “free hiv test kit” searches without a promise, plus appointment request pages that keep answers off the web and away from tracking tools. Our front desk tools hand recent exposures to a clinician or the on-call line, emergencies and overdoses to the 911 line, crises to the 988 line, and questions about results to a clinician or counselor, and do not explain test results. We do not decide who needs testing or treatment; your clinicians do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• USPSTF: Human Immunodeficiency Virus (HIV) Infection: Screening (final recommendation, June 11, 2019; update in progress)
• CDC: Getting Tested for HIV (updated September 15, 2026)
• HIV.gov: HIV Testing Overview (updated August 28, 2026)
• HIV.gov: Viral Suppression and an Undetectable Viral Load (updated October 14, 2026)
• HIV.gov: Post-Exposure Prophylaxis (PEP) (updated October 28, 2026)
• MedlinePlus: HIV (last updated March 26, 2025)
• MedlinePlus: HIV Screening Test (last updated May 6, 2025)
• Medicare.gov: Human Immunodeficiency Virus (HIV) screenings (checked October 30, 2026)
• 42 CFR 2.12: Applicability
• 42 CFR 2.31: Consent requirements
• 45 CFR 164.501: Definitions
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• FDA: Questions and Answers on Dietary Supplements (content current as of August 27, 2026)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7a: Civil monetary penalties
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing